The firm owned 31,906 shares of the financial services provider's stock after buying an additional 2,167 shares during the period. For the current year the company's revenue estimates are $14.96B compared to low analyst estimates of $14.79B and high estimates of $15.08B according to the projection of 17 analysts.
Several other equities analysts also recently weighed in on SYF. The stock of Synchrony Financial (NYSE:SYF) earned "Buy" rating by Deutsche Bank on Wednesday, May 4. The company reported its last quarter on 12/30/2016. FMR LLC increased its stake in shares of Synchrony Financial by 44.7% in the fourth quarter. Finally, SRB Corp increased its position in Synchrony Financial by 23.1% in the third quarter. Raymond James Trust N.A. now owns 6,625 shares of the financial services provider's stock valued at $227,000 after buying an additional 274 shares during the last quarter.
Analysts await Synchrony Financial (NYSE:SYF) to report earnings on July, 28.
Kite Pharma, Inc. (NASDAQ:KITE) closed down -10.79 points or -13.19% at $70.99 with 8.04 mln shares exchanging hands.
Looking at the current price of the stock and the 52 week high and low, it suggests that the stock is likely to go Up in the future. The stock has a market capitalization of $23.02 billion, a P/E ratio of 10.83 and a beta of 1.06. The stock has a 50-day moving average price of $32.57 and a 200 day moving average price of $34.12.
Synchrony Financial (NYSE:SYF) last posted its quarterly earnings data on Friday, April 28th. (Liquidity) Value. Synchrony Financial (NYSE:SYF) has a current Q.i. value of 56.00000. The high and low revenue estimates for the current quarter are $3.66 Billion and $3.54 Billion, respectively. During the same period previous year, the company posted $0.70 earnings per share.
If you look at the company's income statement over the past years, you will see that the company is constantly posting gross profit: In 2014, SYF earned gross profit of 0, in 2015 0 gross profit, while in 2016 Synchrony Financial (SYF) produced 0 profit.
Trump Corrals Conservatives Behind Obamacare Repeal Bill
The lower chamber approved the measure in a 382-30 vote and the upper chamber approved the bill by unanimous consent. She said Republicans who support the revised version will have "doo-doo on their shoe, a tattoo on their forehead".
The firm also recently declared a quarterly dividend, which will be paid on Thursday, May 18th. Stockholders of record on Monday, May 8th will be given a $0.13 dividend. Vanguard Group Inc owns $1.42 billion in SYNCHRONY FINANCIAL, which represents roughly 6.2% of the company's market cap and approximately 6.87% of the institutional ownership. The ex-dividend date of this dividend is Thursday, May 4th. Synchrony Financial's dividend payout ratio (DPR) is presently 19.19%.
TRADEMARK VIOLATION WARNING: "Bbva Compass Bancshares Inc. Boosts Position in Synchrony Financial (SYF)" was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this news story on another domain, it was illegally copied and republished in violation of US and worldwide copyright & trademark laws. Oppenheimer Holdings Inc. reaffirmed a "hold" rating on shares of Synchrony Financial in a report on Sunday, April 30th.
Sell-side analyst recommendations point to a short term price target of $36 on the shares of SYNCHRONY FINANCIAL (SYF).
03/29/2017 - Wells Fargo began new coverage on Synchrony Financial giving the company a "outperform" rating. Vetr lowered shares of Synchrony Financial from a strong-buy rating to a buy rating and set a $41.65 price objective on the stock.in a research note on Tuesday, February 14th. By reviewing stock prices from the stock market history of the company and examining its analysts ratings can give an investment picture with updated information of stock which helps investors to make investing decision. They now have a United States dollars 41 price target on the stock. Finally, BMO Capital Markets reiterated a buy rating and set a $38.00 price target on shares of Synchrony Financial in a research note on Tuesday, April 11th. The stock appeared -25.79% below its 52-week highs and is down -2.23% for the last five trades. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link.
In other news, Director Will W. Graylin acquired 18,000 shares of the stock in a transaction on Monday, May 1st.
In the transaction dated April 03, 2017, the great number of shares disposed came courtesy the See remarks; MELITO DAVID P disposed a total of 600 shares at an average price of $34.11, amounting to approximately $20,466. Following the completion of the transaction, the director now directly owns 55,389 shares of the company's stock, valued at $1,539,814.20. The disclosure for this purchase can be found here. Over the last 90 days, insiders sold 9,457 shares of company stock worth $339,056.
According to Zacks, "Synchrony Financial is a consumer financial services company". The Company provides a range of credit products through programs it has established with a group of national and regional retailers, local merchants, manufacturers, buying groups, industry associations and healthcare service providers.
Comments